{"id":33948,"date":"2026-02-14T21:57:06","date_gmt":"2026-02-14T21:57:06","guid":{"rendered":"https:\/\/bihavadis.com\/?p=33948"},"modified":"2026-02-14T21:57:06","modified_gmt":"2026-02-14T21:57:06","slug":"eczacilikta-istihdam-sorunu","status":"publish","type":"post","link":"https:\/\/bihavadis.com\/index.php\/2026\/02\/14\/eczacilikta-istihdam-sorunu\/","title":{"rendered":"Eczac\u0131l\u0131kta \u0130stihdam Sorunu"},"content":{"rendered":"<p>\n<p>T\u00dcRK Eczac\u0131lar\u0131 Birli\u011fi (TEB) Ba\u015fkan\u0131 \u0130rfan Demirci, &#8220;Bug\u00fcn T\u00fcrkiye&#8217;de yakla\u015f\u0131k 31 bin serbest eczane bulunmas\u0131na kar\u015f\u0131l\u0131k eczac\u0131l\u0131k fak\u00fcltelerinde t\u00fcm s\u0131n\u0131f d\u00fczeylerinde toplam 25 bin 524 \u00f6\u011frenci e\u011fitim g\u00f6r\u00fcyor. Gen\u00e7 meslekta\u015flar\u0131m\u0131z\u0131 istihdam anlam\u0131nda zorlayan tablonun nedeni budur. Bu tablo, kontenjan planlamas\u0131n\u0131n acilen uzun vadeli ve sorumlu bi\u00e7imde yap\u0131lmas\u0131n\u0131n zorunlulu\u011funu a\u00e7\u0131k\u00e7a ortaya koyuyor&#8221; dedi.<\/p>\n<p>TEB Ba\u015fkan\u0131 \u0130rfan Demirci, birli\u011fin kurulu\u015funun 70&#8217;inci y\u0131l d\u00f6n\u00fcm\u00fc nedeniyle Ankara&#8217;da bas\u0131n toplant\u0131s\u0131 d\u00fczenledi. Demirci, T\u00fcrkiye&#8217;nin, Ekonomik Kalk\u0131nma ve \u0130\u015f Birli\u011fi \u00d6rg\u00fct\u00fc (OECD) \u00fcyesi \u00fclkeler aras\u0131nda sa\u011fl\u0131k harcamalar\u0131na en d\u00fc\u015f\u00fck pay ay\u0131ran \u00fclkelerden biri oldu\u011funu belirterek, &#8220;T\u00fcrkiye&#8217;de toplam sa\u011fl\u0131k harcamalar\u0131n\u0131n GSYH i\u00e7indeki pay\u0131 y\u00fczde 5,3&#8217;t\u00fcr. OECD ortalamas\u0131 ise y\u00fczde 9,3 olup, bir\u00e7ok geli\u015fmi\u015f \u00fclkede bu oran y\u00fczde 10&#8217;un \u00fczerindedir. T\u00dc\u0130K&#8217;in sa\u011fl\u0131k harcamalar\u0131yla ilgili a\u00e7\u0131klad\u0131\u011f\u0131 rakamlarda; 2024 y\u0131l\u0131nda toplam sa\u011fl\u0131k harcamas\u0131 bir \u00f6nceki y\u0131la g\u00f6re y\u00fczde 89,6 artarak 2,3 trilyon TL&#8217;ye y\u00fckseldi. Ama burada dikkat \u00e7ekici k\u0131s\u0131m \u015fu; vatanda\u015f\u0131n cebinden de sa\u011fl\u0131k harcamalar\u0131 i\u00e7in 442,3 milyar TL \u00e7\u0131kt\u0131. Yani toplam sa\u011fl\u0131k harcamalar\u0131 i\u00e7inde vatanda\u015f\u0131n cepten \u00f6dedi\u011fi tutar artarak y\u00fczde 19&#8217;a kadar \u00e7\u0131km\u0131\u015f. OECD \u00fclkelerinde ki\u015fi ba\u015f\u0131 ila\u00e7 harcamas\u0131 ortalama 570 dolar civar\u0131ndayken, T\u00fcrkiye&#8217;de bu tutar yakla\u015f\u0131k 131 dolar seviyesinde bulunuyor. Bunun \u00f6tesinde, yenilik\u00e7i ve yeni molek\u00fcl ila\u00e7lara eri\u015fim konusunda T\u00fcrkiye, Avrupa&#8217;n\u0131n \u00e7ok gerisinde yer al\u0131yor. Avrupa&#8217;da yenilik\u00e7i ila\u00e7lara ortalama eri\u015fim oran\u0131 y\u00fczde 46 d\u00fczeyindeyken, T\u00fcrkiye&#8217;de bu oran y\u00fczde 3 seviyesine kadar gerilemi\u015f durumda. Kanser ila\u00e7lar\u0131 \u00f6zelinde bak\u0131ld\u0131\u011f\u0131nda bu tablo \u00e7ok daha \u00e7arp\u0131c\u0131; Avrupa&#8217;da EMA onay\u0131 alan her iki kanser ilac\u0131ndan biri hastalara sunulabilirken, T\u00fcrkiye&#8217;de bu oran y\u00fczde 4 d\u00fczeyinde&#8221; ifadelerini kulland\u0131.<\/p>\n<p>&#8216;GE\u00c7EN YIL ECZANELERDE 504 M\u0130LYON RE\u00c7ETE \u0130\u015eLEM G\u00d6RD\u00dc&#8217;<\/p>\n<p>Demirci, ge\u00e7en y\u0131l\u0131n rakamlar\u0131na g\u00f6re eczanelerde yakla\u015f\u0131k 504 milyon re\u00e7etenin i\u015flem g\u00f6rd\u00fc\u011f\u00fcn\u00fc aktararak, &#8220;Bu devasa rakam, vatanda\u015f\u0131n en yak\u0131n sa\u011fl\u0131k dan\u0131\u015fman\u0131n\u0131n eczac\u0131 oldu\u011fu anlam\u0131na geliyor. Hastalar\u0131m\u0131z tedavileri i\u00e7in eczaneye gittiklerinde e\u011fer ila\u00e7lar\u0131n\u0131 bulam\u0131yorlarsa bu sorunu \u00e7\u00f6zmek i\u00e7in en ba\u015fta meslekta\u015flar\u0131m\u0131z var g\u00fcc\u00fcyle u\u011fra\u015f\u0131yorlar. \u0130la\u00e7 yokluklar\u0131 eczac\u0131lar\u0131n iradesi ya da tercihleriyle ortaya \u00e7\u0131kan bir durum da de\u011fildir. \u0130la\u00e7 yokluklar\u0131n\u0131n temel nedeni; mevcut fiyatland\u0131rma modelinin ekonomik ger\u00e7eklerle uyumsuzlu\u011fu ve bu nedenle de ila\u00e7lar\u0131n yeterli ve s\u00fcrd\u00fcr\u00fclebilir bi\u00e7imde sunulamamas\u0131d\u0131r. &#8216;Bulunamayan ila\u00e7 ihbar hatt\u0131&#8217; gibi uygulamalar\u0131n nihai bir \u00e7\u00f6z\u00fcm olaca\u011f\u0131n\u0131 d\u00fc\u015f\u00fcnm\u00fcyoruz. Aksine hasta ile eczac\u0131y\u0131 kar\u015f\u0131 kar\u015f\u0131ya getirme riskini ta\u015f\u0131maktad\u0131r. Kal\u0131c\u0131 \u00e7\u00f6z\u00fcm; kamu kaynaklar\u0131n\u0131n etkin kullan\u0131m\u0131n\u0131 esas alan, ila\u00e7 b\u00fct\u00e7esini korurken ilac\u0131n \u00fcretimden hastaya kadar t\u00fcm zincirde \u00f6ng\u00f6r\u00fclebilir ve s\u00fcrd\u00fcr\u00fclebilir bi\u00e7imde sunulmas\u0131n\u0131 sa\u011flayan bir ila\u00e7 fiyatland\u0131rma ve geri \u00f6deme modelinin hayata ge\u00e7irilmesi ile m\u00fcmk\u00fcnd\u00fcr&#8221; diye konu\u015ftu.<\/p>\n<p>Eczac\u0131l\u0131k alan\u0131nda ya\u015fanan sorunlar\u0131n 2 ana temelden beslendi\u011fini s\u00f6yleyen Demirci, &#8220;Bunlardan birincisi ekonomik ko\u015fullar, ikincisi de istihdam dengesini bozan kontenjan fazlal\u0131\u011f\u0131na dayal\u0131 yap\u0131. Bug\u00fcn T\u00fcrkiye&#8217;de yakla\u015f\u0131k 31 bin serbest eczane bulunmas\u0131na kar\u015f\u0131l\u0131k eczac\u0131l\u0131k fak\u00fcltelerinde t\u00fcm s\u0131n\u0131f d\u00fczeylerinde toplam 25 bin 524 \u00f6\u011frenci e\u011fitim g\u00f6r\u00fcyor. Gen\u00e7 meslekta\u015flar\u0131m\u0131z\u0131 istihdam anlam\u0131nda zorlayan tablonun nedeni budur. Bu tablo, kontenjan planlamas\u0131n\u0131n acilen uzun vadeli ve sorumlu bi\u00e7imde yap\u0131lmas\u0131n\u0131n zorunlulu\u011funu a\u00e7\u0131k\u00e7a ortaya koyuyor&#8221; dedi. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>TEB Ba\u015fkan\u0131 Demirci, eczac\u0131l\u0131kta kontenjan fazlal\u0131\u011f\u0131n\u0131 ve sa\u011fl\u0131k harcamalar\u0131ndaki eksiklikleri vurgulad\u0131.<\/p>\n","protected":false},"author":1,"featured_media":33949,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[5046,5047,660,812,517],"class_list":["post-33948","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ekonomi","tag-eczaci","tag-eczane","tag-ilac","tag-tablo","tag-turk"],"_links":{"self":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/33948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/comments?post=33948"}],"version-history":[{"count":1,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/33948\/revisions"}],"predecessor-version":[{"id":33950,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/33948\/revisions\/33950"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/media\/33949"}],"wp:attachment":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/media?parent=33948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/categories?post=33948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/tags?post=33948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}